Nestlé Not Interested In Wider Consumer Health Play, Will Stick To VMS And Nutrition
Executive Summary
While Nestle has made a success of its push into the dietary supplements market, don't expect to see the company make a move into the wider consumer health space. The company's Health Science unit recorded double-digit growth in 2021, but will remain focused on its core categories.
You may also be interested in...
With Investor Support Thin On The Ground, Unilever Won't Up Bid For GSK Consumer Healthcare
Unilever's decision not to increase its £50bn bid for GSK Consumer Healthcare has been widely welcomed by analysts. But they warn that the aborted move for GSK has damaged investor confidence in Unilever’s management.
Nestlé Weighing Acquisition Of The Bountiful Company
Nestlé is in talks to acquire "all or part" of The Bountiful Company, owners of the Nature's Bounty brand and a leading player in the US supplements market. The Swiss firm revealed its interest in The Bountiful Company shortly after reporting double-digit growth at its Health Science business in Q1.
Vital Proteins’ ‘Timely’ Immunity Product Launch Makes Time Right For Nestle Investment
Nestle Health Science has majority stake in US firm that started offering a powder blend for beverages containing vitamin C, collagen, L glutamine, zinc, electrolytes and beta glucan earlier in 2020, when consumer interest spiked in boosting immunity health.